Isolated rat hepatocytes in primary monolayer culture were maintained for [18][19][20][21][22][23][24] 
INTRODUCTION
Vasopressin and other Ca2"-mobilizing hormones stimulate the breakdown of PIP2 to yield IP3, which subsequently mobilizes Ca21 from intracellular stores such as the endoplasmic reticulum (Nishizuka, 1986; Berridge, 1987) . Glucagon or cyclic AMP analogues can also increase [Ca2"]i (Poggioli et al., 1986; Combettes et al., 1986) . The effects of glucagon and vasopressin appear to be additive in this respect (Altin & Bygrave, 1987; Whipps et al., 1987; Poggioli et al., 1986; Combettes et al., 1986; Blackmore & Exton, 1986) . The mechanism by which glucagon may be acting is not known, and there is a lack of agreement as to whether glucagon by itself, or in combination with vasopressin, stimulates PIP2 hydrolysis to produce IP3. In this report we show that cyclic AMP or glucagon had no significant effect on basal inositol phosphate synthesis, but enhanced the effects of vasopressin.
MATERIALS AND METHODS Preparation and incubation of hepatocytes
Hepatocytes were prepared as described by Pittner et al. (1985) . The Downes & Michell (1981) 
RESULTS AND DISCUSSION
Although both vasopressin and glucagon increase intracellular [Ca2+] , the mechanism by which glucagon acts is unknown. One possibility is that glucagon directly or indirectly activates PIP2 breakdown, releasing IP3, which in turn releases Ca2+1 from internal stores such as the endoplasmic reticulum. Another possibility is that a Ca2+ gate located on the plasma membrane is directly regulated by a cyclic-AMP-dependent process allowing entry of external Ca21 (Poggioli et al., 1986) . Wakelam et al. (1986) reported that glucagon at concentrations between 0.5 and 5 nm increased IP3 synthesis by 20 0, as did a glucagon analogue that did not affect cyclic AMP concentrations; they found no effect of glucagon at concentrations above 5 nM on inositol phosphate accumulation. However, Exton (1986) and Charest et al. (1985) reported 6 30 o increases in IP3 accumulation with glucagon at concentrations that were found to be ineffective by Wakelam et al. (1986) . In contrast, Poggioli et al. (1986) found no effect ofglucagon on phosphoinositide metabolism. We also found no effect of glucagon alone on phosphoinositide breakdown, using cultured rat hepatocytes (Table 1) .
In our experiments, if hepatocytes were incubated with 100 ,#M-8Br-cAMP or 10 nM-glucagon for 5 min or 8 h in the presence of Li', no significant change in net accumulation of labelled inositol phosphates was seen (Table 1) . If vasopressin was added to hepatocytes that had been previously treated with 8Br-cAMP or glucagon for 5 min, an enhancement of the effects of vasopressin was seen (Table 1) , in agreement with the findings of Blackmore & Exton (1986) and in contrast with those of Poggioli et al. (1986) . Similar results were also seen if the hepatocytes had been incubated with 8Br-cAMP or glucagon for 8 h (Table 1 ) before the addition of vasopressin. There was no effect of vasopressin or 8Br-cAMP on the concentration of glycerophosphoinositol (results not shown).
8Br-cAMP did not alter the responsiveness of the hepatocytes to vasopressin (Fig. 1) , since maximum effects were seen with 10 nM-vasopressin in either the presence or the absence of the cyclic AMP analogue. The enhancement was predominantly of IP2 and IP3 (+tetrakisphosphate) accumulation (Fig. 1) . Increases in the vasopressin response required between 0.1 and 1 /LM-8Br-cAMP (Fig. 2) .
The maximum response to 8Br-cAMP was seen if the hepatocytes were preincubated for approx. 1 h before the addition of vasopressin. The effect was long lasting, as it was the same whether 8Br-cAMP was added 1 or 12 h before the addition of vasopressin (Fig. 3 ).
8Br-cGMP (100 gM) did not mimic the effects of 8Br-cAMP ( Table 2) . The effect of 100 ,tM-8Br-cGMP on accumulation of IP3 even after 8 h was less than that noted with 0.1 /,tM-8Br-cAMP (Fig. 2) . The only effect of 100I M-Br-cGMP was a small enhancement, after 8 h incubation, of 1P1 accumulation in the presence of vasopressin (Table 2) . Whipps et al. (1987) reported an effect of a 10 min incubation with glucagon on labelling of PIP and PIP2 in [Vasopressin] (nM) Fig. 1 . Effects of 8 h exposure to 8Br-cAMP on vasopressin-mediated stimulation of inositol phosphate production Hepatocytes were incubated in the absence (0) or the presence (@) of 8Br-cAMP (100 /M) for 8 h and then exposed to various concentrations of vasopressin for 5 min, and inositol phosphate production was measured as described in the Materials and methods section. Results are expressed as the inositol phosphate production as a percentage of that of basal incubations in the absence of any added hormones, which were 1700 + 315, 112 + 18 and 147 + 33 d.p.m. for IP1, IP2 and IP3 respectively, and are means + ranges of two independent experiments. Vol. 257 (Table 3 ). There was also no effect of vasopressin with or without 8Br-cAMP, which is hardly surprising, since a 5 min incubation with vasopressin even in the presence of 8Br-cAMP results in breakdown of less than 2 % of labelled phosphoinositides (Tables 1 and 3) . We found that most of the basal inositol phosphates consisted of inositol 1-phosphate (Fig. 4) . Vasopressin particularly increased the accumulation of label in I(4)P, I(1,4)P2 and I(1,4,5)P3. An 8 h incubation with 8Br-cAMP before the addition of vasopressin appeared simply to increase the accumulation of label in all the inositol phosphates, suggesting that the action of 8Br-cAMP is a mere amplification of the actions of vasopressin.
Over an 8 h period there is a marked induction of the enzymes phosphatidate phosphohydrolase and tyrosine aminotransferase by dexamethasone (a synthetic glucocorticoid) or by cyclic AMP in cultured rat hepatocytes (Pittner et al., 1985) . The combination of both agents results in a greater stimulation of enzyme activity than was seen with either alone. Dexamethasone (100 nM) had little effect on basal or vasopressinstimulated inositol phosphate formation (Table 4) . However, accumulation of IP3 owing to vasopressin in hepatocytes that had been incubated for 8 h with 8Br-cAMP and dexamethasone was 34 % greater than in hepatocytes exposed to 8Br-cAMP alone (Table 4 ). The data show that the effect of dexamethasone was specific for IP3 accumulation, suggesting an effect on the enzyme(s) responsible for IP3 metabolism.
Actinomycin D (an inhibitor of mRNA synthesis) and cycloheximide (an inhibitor of protein synthesis) had surprisingly little effect on basal or vasopressinstimulated inositol phosphate concentrations, even in the presence of 8Br-cAMP (Table 4 ). The data suggest that the long-term effect of 8Br-cAMP is not due to protein synthesis de novo, and indicate that the proteins involved Length of preincubation with 8Br-cAMP (h) Fig. 3 . Time course for the effects of 8Br-cAMP on vasopressinmediated stimulation of inositol phosphate production Hepatocytes were incubated with 100 1M-8Br-cAMP for the times indicated before addition of vasopressin for 5 min. Zero preincubation represents simultaneous addition of 8Br-cAMP and vasopressin for 5 min. Inositol phosphate production was measured as described in the Materials and methods section. Results are expressed as the production of IP1 (O), 1P2 (A) and 1P3 (0) compared with incubations containing vasopressin alone, which were normalized to 100 % as in Fig. 2 , and are means from three independent experiments, except for the 15 min, 4 h and 12 h time points, which are means from two independent experiments; S.E.M. values and ranges have been omitted for the sake of clarity. Table 1 , and applied to a SAX h.p.l.c. column as described in the Materials and methods section. The percentage of 1.7 M-ammonium formate (pH 3.7) present in the elution gradient ( . ) is shown in panel (a), and the relative positions of I(l)P, I(4)P, 1(1,4)P2 and 1(1,4,5)P3 identified by using radioactive standards are noted in panel (b) . Panel (a) shows the elution profile of [3H]inositol phosphates in hepatocytes from basal incubations (0), (b) shows that from hepatocytes incubated with 100 nM-vasopressin (A) for 5 min, and (c) shows that from hepatocytes incubated for 8 h with 100 1zM-8Br-cAMP before the addition of 100 nM-vasopressin (El) for 5 min. The fraction size was 0. The site of cyclic AMP action remains to be established. The three most likely possibilities are phosphorylation of the vasopressin receptor, the putative 'Gp' protein as suggested by Blackmore & Exton (1986) , or the phospholipase C enzyme itself.
